Box score
Ollin Biosciences, Inc.
Reported $156M sold in a new Form D filed June 24, 2026 (Austin, Texas).
- Biggest raise
- $156M filed Jun 24, 2026
- League
- Bio & Health Biotechnology
- Based in
- Austin, Texas
- Season rank
- #5 of 1,121 in the Bio & Health League; #125 of 10,745 overall (2026)
- Incorporated
- 2022
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-06-24 | New notice | $156M | $330M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2141184.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Lexicon Pharmaceuticals, Inc. | Bio & Health | $55.7M |
| 2 | Baylor Genetics Holdings, Inc. rookie | Bio & Health | $50M |
| 3 | Cosmetic Physician Partners, LLC | Bio & Health | $40M |
| 4 | Faeth Therapeutics, Inc. rookie | Bio & Health | $24.4M |
| 5 | Klinic Inc rookie | Bio & Health | $23.9M |
| 6 | CNS Pharmaceuticals, Inc. rookie | Bio & Health | $22.5M |